CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 2,583 enrolled
Drug / intervention
Divazadrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04370028
NCT04370028N/ACompleted
CompareCT.gov

All-Russian Observational Non-interventional Study on Efficacy and Safety of Divaza in Patients With Chronic Cerebral Ischemia and Cognitive Disorders

Materia Medica Holding·observational·Posted Apr 30, 2020·Updated Mar 10, 2021

In Brief

An observational study evaluating Divaza for Chronic Cerebral Ischemia. Completed, enrolled 2,583 participants.

Detailed Summary

An open-label, prospective, observational, multicenter study. The study enrolls adult outpatients with CCI from 8 federal districts of the Russian Federation.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Cerebral Ischemia
Countries--
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedApr 30, 2020
Enrollment StartOct 1, 2016
Primary CompletionJan 1, 2017
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 6.2 years ago

Interventions

Divazadrug

Oral administration.